Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| HET0016 | C12H18N2O | 339068-25-6 | Details |
| Palonosetron hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| HCV-IN-29 | C26H32Cl4N6 | 1009119-83-8 | Details |
| Cathepsin Inhibitor 2 | C19H21F6N3O | 1017931-53-1 | Details |
| Hydroxyzine D8 | C21H19ClD8N2O2 | 1189480-47-4 | Details |
| Heptamidine dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
| HWL-088 | C22H19FO4 | 2378617-96-8 | Details |
| HLY78 | C17H17NO2 | 854847-61-3 | Details |
| IBR2 | C24H20N2O2S | 313526-24-8 | Details |
| Leflunomide | C12H9F3N2O2 | 75706-12-6 | Details |
| Ibrutinib dimer | C50H48N12O4 | 2031255-23-7 | Details |
| hGPR91 antagonist 1 | C31H23F4N3O | 1314796-00-3 | Details |
| Ibrutinib-MPEA | C32H39N9O2 | 1710768-30-1 | Details |
| IDH1 Inhibitor 2 | C26H22N4O | 2244895-42-7 | Details |
| hDHODH-IN-1 | C17H14N2O2 | 1173715-42-8 | Details |
| HCV-IN-7 hydrochloride | C40H49ClN8O6S | 1449756-87-9 | Details |
| HA155；CS-963 | C24H19BFNO5S | 1312201-00-5 | Details |
| Hydroxy ziprasidone | C21H21ClN4O2S | 884305-08-2 | Details |
| Helioxanthin 8-1；Helioxanthin analogue 8-1 | C20H12N2O6 | 840529-13-7 | Details |
| Hexyl gallate | C13H18O5 | 1087-26-9 | Details |
| GW311616 | C19H31N3O4S | 198062-54-3 | Details |
| HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
| Heme Oxygenase-1-IN-1；HO-1-IN-1 | C13H15BrN2 | 1093058-52-6 | Details |
| Prothionamide | C9H12N2S | 14222-60-7 | Details |
| Trimethoprim | C14H18N4O3 | 738-70-5 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| ICI 118,551 hydrochloride | C17H28ClNO2 | 72795-01-8 | Details |
| HIF-2α-IN-3 | C12H6ClN5O5 | 313964-19-1 | Details |
| HSV-TK substrate | C11H15N5O4 | 111687-37-7 | Details |
| HS80 | C19H22N4S | 2138838-57-8 | Details |
| HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
| Encequidar | C38H36N6O7 | 849675-66-7 | Details |
| Encequidar mesylate | C39H40N6O10S | 849675-87-2 | Details |
| HCV-IN-30 | C36H44N6O4 | 1007882-23-6 | Details |
| Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
| Ibuprofen-d3；(±)-Ibuprofen D3;Ibuprofen D3 | C13H15D3O2 | 121662-14-4 | Details |
| Hydroxyzine D4 | C21H27ClN2O2 | 2070014-84-3 | Details |
| H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
| IAXO-102 | C35H71NO5 | 1115270-63-7 | Details |
| (-)-Ibuprofenamide；(R)-Ibuprofenamide | C13H17NO3 | 121839-78-9 | Details |
| IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
| Moxidectin | C37 H53 N O8 | 113507-06-5 | Details |
| Rifaximin | C43H51N3O11 | 80621-81-4 | Details |
| Helioxanthin derivative 5-4-2；Helioxanthin 5-4-2 | C20H13NO5 | 203935-39-1 | Details |
| Heme Oxygenase-1-IN-1 hydrochloride；HO-1-IN-1 hydrochloride | C13H16BrClN2 | 1092851-70-1 | Details |
| H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
| hDHODH-IN-2 | C19H16N2O2 | 183946-00-1 | Details |
| HIV-1 integrase inhibitor | C11H9N3O4 | 544467-07-4 | Details |
| Hydroxycitric acid tripotassium hydrate；Potassium citrate monohydrate | C6H11KO8 | 6100-05-6 | Details |
| HKI-357 | C31H29ClFN5O3 | 848133-17-5 | Details |
| HDAC-IN-4 | C20H21N3O2 | 1252003-13-6 | Details |
| HIV-1 integrase inhibitor 4 | C24H20F2N4O5S | 1638504-66-1 | Details |
| HDACs/mTOR Inhibitor 1 | C28H38N8O5 | 2271413-06-8 | Details |
| HS79 | C19H22N4S | 2138838-56-7 | Details |
| HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
| DPP-IV-IN-2 | C18H26N4O5 | 136259-18-2 | Details |
| Haloperidol D4 | C21H19ClD4FNO2 | 1189986-59-1 | Details |
| Ibrutinib-d5；PCI-32765 D5;Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
| Hydroxybupropion | C13H18ClNO2 | 92264-81-8 | Details |
| HIF-2α-IN-2 | C17H13F2NO4S | 1672666-82-8 | Details |
| H100 | C18H16N2O6S | 643727-55-3 | Details |
| IACS-8803 | C20H23FN10O9P2S2 | 2095690-70-1 | Details |
| hDDAH-1-IN-1 TFA | C10H21F3N4O3 | 1229238-70-3 | Details |
| HSL-IN-1 | C19H13BClF3N2O4 | 2095156-13-9 | Details |
| Hydroxyamine hydrochloride | NH2OH·HCl | 5470-11-1 | Details |
| Phenoxybenzamine hydrochloride | C18H22ClNO.ClH | 63-92-3 | Details |
| IACS-9571；ASIS-P040 | C32H42N4O8S | 1800477-30-8 | Details |
| (-)-Hydroxycitric acid；Garcinia acid | C6H8O8 | 27750-10-3 | Details |
| Fusidic acid | C31H48O6 | 6990-06-3 | Details |
| HIV-1 integrase inhibitor 3 | C21H22F2N4O4 | 1638504-56-9 | Details |
| GW311616 hydrochloride；GW311616A | C19H32ClN3O4S | 197890-44-1 | Details |
| IDH1 Inhibitor 3 | C31H25F4N5O3 | 2171081-24-4 | Details |
| Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
| Hydroxy desmethyl Bosentan；Ro 64-1056 | C26H27N5O7S | 253688-62-9 | Details |
| Mebendazole | C16H13N3O3 | 31431-39-7 | Details |
| HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
| Epanolol；Visacor;ICI141292 | C20H23N3O4 | 86880-51-5 | Details |
| I2906 | C25H37N3O4 | 331963-29-2 | Details |
| Ibiglustat (L-Malic acid) | C24H30FN3O7S | 1629063-78-0 | Details |
| H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
| H-Ser-His-OH | C9H14N4O4 | 67726-09-4 | Details |
| Haloperidol (D4')；Haloperidol D4' | C21H19ClD4FNO2 | 136765-35-0 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| I-OMe-Tyrphostin AG 538 | C17H12INO5 | 1094048-77-7 | Details |
| Heptamidine；SBi4211 | C21H28N4O2 | 94345-47-8 | Details |
| BAY 59-9435；HSL-IN-2 | C14H22N2O3 | 654059-21-9 | Details |
| Idelalisib D5；CAL-101 D5;GS-1101 D5 | C22H18FN7O | 1830330-31-8 | Details |
| ICI 153110 | C11H11N3O | 87164-90-7 | Details |
| H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
| HSR6071 | C10H12N8O | 111374-21-1 | Details |
| FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
| HIV-1 inhibitor-3 | C9H10F2N2O5 | 1612841-22-1 | Details |
| Helvolic acid；Fumigacin | C33H44O8 | 29400-42-8 | Details |
| HCV-IN-3 | C13H11F2NO | 1401839-25-5 | Details |
| HSL-IN-3 | C14H19BO4 | 346656-34-6 | Details |
| HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
| Haemanthamine | C17H19NO4 | 466-75-1 | Details |
| Heptasaccharide Glc4Xyl3 | C39H66O33 | 121591-98-8 | Details |
| Product Total： Product Page： | ||||
| 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 | ||||